John G. Curd
Plus aucun poste en cours
Provenance du réseau au premier degré de John G. Curd
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.
108
| Subsidiary | Biotechnology | 108 |
Novacea, Inc.
 Novacea, Inc. Pharmaceuticals: MajorHealth Technology Novacea, Inc. is a privately held biopharmaceutical company focused on licensing, developing and commercializing novel agents to revolutionize the treatment of cancer. Novacea’s in-licensed product portfolio features three clinical stage oncology therapeutics. The Company has two products which are anticipated to commence Phase 3 clinical trials in 2006, DN-101 and vinorelbine oral. Banoxantrone (AQ4N) is in Phase 1/2 clinical trials. It is located in South San Francisco, CA.
13
| Extinct | Pharmaceuticals: Major | 13 |
Threshold Pharmaceuticals, Inc.
 Threshold Pharmaceuticals, Inc. BiotechnologyHealth Technology Threshold Pharmaceuticals, Inc. engages in the development of therapeutics for treating tumors. It offers the Evofosfamide which designed as a prodrug that is activated under the extreme hypoxic conditions commonly found in tumors, but not typically in healthy tissues, and TH-3424 which is a small-molecule drug candidate for the treatment of liver, castrate resistant prostate cancer, T-cell acute lymphoblastic leukemias, and other cancers. The company was founded by Jeffrey W. Bird on October 17, 2001 and is headquartered in South San Francisco, CA
8
| Extinct | Biotechnology | 8 |
VaxGen, Inc.
 VaxGen, Inc. BiotechnologyHealth Technology VaxGen, Inc. is a biopharmaceutical company, owns a state-of-the-art biopharmaceutical manufacturing facility that can be used to make cell culture or microbial biologic products. The company has ended all product development activities and sold or otherwise terminated its drug development programs. It is seeking to maximize the value of its remaining tangible and intangible assets through a transaction or series of transactions, including the sale of the manufacturing facility. The company was founded on November 01, 1995 and is headquartered in South San Francisco, CA.
4
| Extinct | Biotechnology | 4 |
Scripps Clinic Foundation
2
| Foundation/Endowment | Hospital/Nursing Management | 2 |
Maxygen, Inc.
 Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA.
1
| Private Company | Miscellaneous Commercial Services | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à John G. Curd via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| The University of California, San Francisco | College/University | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree | |
| University of California, Berkeley | College/University | Graduate Degree Undergraduate Degree Doctorate Degree Corporate Officer/Principal Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Chairman Chairman Chairman Corporate Officer/Principal Director/Board Member | |
| AMGEN INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Director of Finance/CFO Director/Board Member Public Communications Contact Corporate Officer/Principal | |
| PDL BIOPHARMA, INC. | Biotechnology | Director/Board Member Director/Board Member Chairman Comptroller/Controller/Auditor General Counsel | |
| HUMANIGEN, INC. | Biotechnology | Chairman Director/Board Member Chairman Director/Board Member General Counsel | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Graduate Degree Undergraduate Degree Doctorate Degree Doctorate Degree Undergraduate Degree | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Director/Board Member Corporate Officer/Principal Chief Tech/Sci/R&D Officer Director/Board Member Public Communications Contact | |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Masters Business Admin Masters Business Admin Graduate Degree Masters Business Admin Graduate Degree | |
| PHARMACYCLICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel General Counsel Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| University of California, Davis | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| University of California San Diego | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Corporate Officer/Principal | |
| PORTOLA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member General Counsel President | |
| PRINCIPIA BIOPHARMA INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Chief Tech/Sci/R&D Officer Human Resources Officer | |
| Massachusetts Institute of Technology | College/University | Director/Board Member Doctorate Degree Undergraduate Degree Undergraduate Degree | |
Samsara Biocapital LLC
 Samsara Biocapital LLC Investment ManagersFinance Samsara Biocapital LLC (Samsara Biocapital) is an independent venture capital firm founded in 2016 by Srinivas Akkaraju. The firm is headquartered in Palo Alto, California. | Investment Managers | Founder General Counsel Consultant / Advisor Human Resources Officer | |
| Stanford University | College/University | Doctorate Degree Masters Business Admin Undergraduate Degree Undergraduate Degree | |
| State University of New York at Buffalo | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree Undergraduate Degree | |
Axys Pharmaceuticals, Inc.
 Axys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Axys Pharmaceuticals, Inc. engages in the development of integrated drugs. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Chief Executive Officer | |
| SEAGEN INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| Vanderbilt University | College/University | Doctorate Degree Undergraduate Degree Corporate Officer/Principal | |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | College/University | Corporate Officer/Principal Doctorate Degree Graduate Degree | |
Monogram Biosciences, Inc.
 Monogram Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Monogram Biosciences, Inc. develops and commercializes diagnostic products for the treatment of human immunodeficiency virus (HIV) infection, hepatitis C virus (HCV) infection, and other viral illnesses, as well as cancer and other diseases. It offers HIV tests, including genotypic, phenotypic, tropism, and combined phenotype and genotype assays, suppression management and viral load testing, HCV assays and oncology tests. The company was founded in 1995 and is headquartered in South San Francisco, CA. | Miscellaneous Commercial Services | Human Resources Officer Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| ZS PHARMA INC | Pharmaceuticals: Major | Director/Board Member General Counsel Director/Board Member | |
The Column Group LLC
 The Column Group LLC Investment ManagersFinance The Column Group LLC is a venture capital firm founded in 2005 by Peter Svennilson. The firm is headquartered in San Francisco. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Medical Specialties | Director/Board Member Chief Tech/Sci/R&D Officer Chief Operating Officer | |
Bill & Melinda Gates Foundation Trust
 Bill & Melinda Gates Foundation Trust Financial ConglomeratesFinance The Bill & Melinda Gates Foundation was formed in 1997 as the William H. Gates Foundation. In 1999, the foundation was renamed the Bill & Melinda Gates Foundation. The Bill & Melinda Gates Foundation Trust was created in January 2000 through the merger of the Gates Learning Foundation, which worked to expand access to technology through public libraries and the William H. Gates Foundation, which focused on improving global health. The foundation participates in preventive approaches and collaborative endeavors with government, philanthropic and not-for-profit partners. Priority is given to grants that leverage additional support and serve as a catalyst for long-term, systemic change. The foundation also provides funds to promote greater equity in global health, education and public libraries. Through their partnerships in communities across the US, the Bill & Melinda Gates Foundation is committed to raising the high school graduation rate and helping all students, regardless of race or family income. The foundation is headquartered in Seattle, Washington. | Financial Conglomerates | Chief Executive Officer Chief Executive Officer Director/Board Member | |
| REGENXBIO INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Operating Officer | |
| INNOVIVA, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Director of Finance/CFO | |
| Golden Gate University | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| XOMA CORPORATION | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| ALZA CORPORATION | Pharmaceuticals: Major | Chief Executive Officer Chairman Corporate Officer/Principal | |
| Brown University | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree | |
| Harvard Medical School | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
| Princeton University | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree | |
| SUTRO BIOPHARMA, INC. | Pharmaceuticals: Major | Director of Finance/CFO Public Communications Contact Director/Board Member | |
| ARCA BIOPHARMA, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member |
Statistiques
Internationale
| Etats-Unis | 51 |
Sectorielle
| Health Technology | 29 |
| Consumer Services | 15 |
| Finance | 6 |
| Commercial Services | 4 |
Opérationnelle
| Director/Board Member | 670 |
| Corporate Officer/Principal | 290 |
| Independent Dir/Board Member | 184 |
| Chairman | 154 |
| Chief Executive Officer | 105 |
Relations les plus connectées
| Insiders | |
|---|---|
| Srini Akkaraju Akkaraju | 54 |
| Michael Powell | 48 |
| James Blair | 48 |
| Daniel Bradbury | 45 |
| Ernest Mario | 44 |
| John P. Walker | 39 |
| Linda Levinson | 32 |
| Deepa Pakianathan | 32 |
| William Young | 32 |
| Ted Love | 31 |
| David Parkinson | 31 |
| Camille Samuels | 30 |
| J. Kenneth Charles Knowles | 29 |
| Samuel Saks | 28 |
| Christopher Ehrlich | 27 |
- Bourse
- Insiders
- John G. Curd
- Connexions Sociétés
